Our series “Ask a Scientist” was constructed from the belief that we should distribute knowledge that helps you become your own catalyst in health-related questions and subsequent personalized health decisions.
Talking about your product will always bore people. Telling them how it solves their problem never will. Seven industries may be seen by some as "unsexy," but there are businesses in each space that have found a way to make what they do sound exciting.
Huffington Post contributor Larry Alton talks about the challenges faced in medical diagnosis and how personalized medicine technologies might help to overcome some of the more significant hurdles. Highlighted are the groundbreaking technologies of both Silene Biotech and 23andMe. Additionally, Larry touches on the impacts of personalized medicine on women's health.
Type 1 diabetes affects more than 1 million people in the United States. In these patients, the immune system attacks and kills the beta cells in the pancreas which produce the insulin necessary to regulate blood sugar. Without these cells, patients must inject doses of insulin to control their blood sugar and carefully monitor what they eat.
The interaction between the various organs and cell types the liver and colon the focus of research in both health and disease. Recently, two labs from the Cincinnati Children’s Hospital Medical Center have developed tools that will greatly benefit the study of these important organs.